Kazia Therapeutics maintained at Buy as BTIG raises target
BTIG maintained Kazia Therapeutics at Buy and raised its price target to $40.00 per share from $34.00, according to Benzinga via TradingView News.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.